Talking Techniques
By BioTechniques
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BioTechniques
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 64
Description
Welcome to Talking Techniques! In this Podcast BioTechniques Digital Editor Tristan Free, interviews researchers at the forefront of their fields about the latest breakthroughs, controversies and conversations in the life sciences. From CRISPR to COVID-19, organoids to the microbiome, this podcast will explore the latest developments in the lab and interesting applications of techniques, while trying to determine how we can drive science forward in progressive and inventive ways.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
The BRAIN miniseries | Exploring the neuropathogenesis of HIV and mentoring the next generation of scientists
|
Mar 17, 2026 |
|
The BRAIN miniseries | Investigating the link between vascular health and neurodegeneration in underrepresented populations
|
Feb 19, 2026 |
|
The BRAIN miniseries | Meet the neuroengineer building brain-monitoring devices and thriving communities
|
Feb 13, 2026 |
|
Cytokine networks in autoimmune diseases: mechanisms, pathogenesis and therapeutic innovations
|
Jun 19, 2025 |
|
Skills-based teaching and microcredentialing in STEM
|
Aug 20, 2024 |
|
Antigen validation and T-cell receptor engineering for cancer immunotherapies
|
Jul 12, 2024 |
|
Cytokines: from therapeutics to diagnostics
|
Jul 10, 2024 |
|
Spatial analysis of the immune-cell-surface proteome at a single-cell resolution
|
Mar 22, 2024 |
|
Investigating the neurological pathways underlying vocal communication
|
Feb 20, 2024 |
|
Rare disease and pharmacogenomics
|
Jan 23, 2024 |
|
One man’s waste in another man’s treasure: using wastewater to monitor infectious diseases
|
Dec 18, 2023 |
|
Next-generation antibody therapeutics
|
Nov 22, 2023 |
|
Investigating resistant leukemia with single-cell technologies
|
Nov 03, 2023 |
|
CAR-T and CAR-NK cell therapies
|
Jul 27, 2023 |
|
Mitochondria, the immune system and cancer: discovering new insights with spatial technologies
|
Jun 16, 2023 |
|
Long-read sequencing, metagenomics and the microbiome
|
May 10, 2023 |
|
Open neuroscience and the meaning of FAIR
|
Feb 03, 2023 |
|
Welcome to the jungle: sequencing for conservation
|
Jan 25, 2023 |
|
Neuropixels: big data heaven or burying the lead in averages?
|
Jan 18, 2023 |
|
Microbiome profiling techniques: from immunology to agriculture
|
Sep 29, 2022 |
|
The gut–brain axis and addiction
|
Sep 28, 2022 |
|
3D cell cultures: the latest developments, applications and regulations in the field
|
Aug 26, 2022 |
|
rAAVs, host-cell contamination and ddPCR
|
Aug 03, 2022 |
|
HPV, epigenetics and cancer: sequencing for new insights and to correct healthcare inequality
|
Jul 28, 2022 |
|
Artificial intelligence in healthcare
|
Jul 20, 2022 |
|
Liquid biopsy and cfNAs: driving forward diagnostics and disease research
|
May 26, 2022 |
|
The evolution of recombinant antibodies
|
Apr 19, 2022 |
|
The epigenetic clock
|
Mar 25, 2022 |
|
Resolving spatial biology in neuroscience
|
Feb 28, 2022 |
|
Introducing STEM Tea
|
Feb 17, 2022 |
|
Cell proliferation in drug screening
|
Jan 25, 2022 |
|
Synthetic biology: from cancer to the climate crisis
|
Dec 21, 2021 |
|
Establishing an epigenetic lens to explore cancer and infectious diseases
|
Nov 12, 2021 |
|
Target enrichment for NGS: why, how and what's next?
|
Oct 26, 2021 |
|
Producing challenging proteins in the golden age of protein engineering
|
Oct 13, 2021 |
|
The evolution of PCR: From q to dd and beyond
|
Sep 21, 2021 |
|
Molecular therapeutics: how far have we come and what's on the horizon?
|
Aug 27, 2021 |
|
Adeno-associated viral therapies: harnessing the power of HPLC
|
Aug 17, 2021 |
|
Organoids: advancing drug discovery and cancer research
|
Aug 16, 2021 |
|
The ethics of whole-genome sequencing: from race and religion to science fiction
|
Jun 25, 2021 |
|
Revitalizing the western blot
|
Jun 21, 2021 |
|
From space to the streets: infectious disease sampling in extreme conditions and extraordinary circumstances
|
Jun 18, 2021 |
|
Revealing the regulome: using multiomic approaches to explore epigenetics and DNA expression
|
Jun 11, 2021 |
|
The oncolytic Trojan horse: Immune cells, the tumor microenvironment and the invasion of neurons
|
May 28, 2021 |
|
Whole-genome-sequencing: navigating the "Diagnostic Odyssey" in rare disease research
|
May 19, 2021 |
|
The wonders of wastewater surveillance for COVID-19
|
Apr 19, 2021 |
|
How PCR has prevailed during the COVID-19 pandemic
|
Mar 30, 2021 |
|
Reproducibility in microbiomics
|
Mar 25, 2021 |
|
How can we achieve gender equality in STEM?
|
Mar 05, 2021 |
|
COG-UK: sequencing SARS-CoV-2 and detecting the novel variant B.1.1.7
|
Feb 18, 2021 |
|
COVID-19 diagnostics: which test should you choose?
|
Jan 15, 2021 |
|
Andy Tay: Forbes, awards and championing diversity in STEM
|
Dec 10, 2020 |
|
How has neuroimaging continued and flourished during the COVID-19 pandemic?
|
Nov 06, 2020 |
|
The reproducibility crisis: where are we now and how can we progress?
|
Oct 20, 2020 |
|
CRISPR: developing an equitable technology amidst a global pandemic
|
Oct 12, 2020 |
|
Helicopter research and the challenges and misconceptions of research in Africa
|
Aug 24, 2020 |
|
Big data and COVID-19 part 2: Affecting policy and revealing risk
|
Aug 10, 2020 |
|
Big data and COVID-19 part 1: Facilitating and using collaborative, open data
|
Aug 10, 2020 |
|
DNA vaccines: combating cancer and COVID-19
|
Aug 10, 2020 |
|
The sustainable lab: energy efficiency, glass vs plastic and human behavior
|
Aug 10, 2020 |
|
UV LEDs for disinfection and potential protection from SARS-CoV-2
|
Aug 10, 2020 |
|
Rob Vries on organoids for drug discovery and the study of COVID-19
|
Aug 10, 2020 |
|
Donald Ingber: How COVID-19 is changing conservatism in life sciences
|
Aug 10, 2020 |
|
Donald Ingber on COVID-19, organ-on-a-chip technology and the Wyss Institute
|
Aug 07, 2020 |